Historical Fiction / Medical Thriller/ Espionage
Date Published: January 1, 2024
In the era of legalized marijuana in the United States, the Chinese government has nefarious plans to exploit America's best and brightest graduate students using synthetic Hallucinogens and THC compounds. To accomplish their goal, the Chinese Communist Party (CCP) has partnered with a disaffected American CIA agent who was instrumental in the CIA's domestic hallucinogen experiments on American citizens known as Project MKULTRA during the Korean and Vietnam wars. The CCP have surreptitiously funded upscale cafés in each American city where marijuana has been legalized and there is an American university within walking distance of their café.
In each café, the CCP secretly adds a designer hallucinogen to the coffee. This drug opens the graduate student's minds to the power of suggestion and allows the baristas (Chinese security agents) to easily question the students for technical information concerning their graduate studies and labs. The methods used are similar to what the disaffected CIA agent learned during his MKULTRA project missions in the 1950s and 1960s. This allows the Communist Chinese to gain a head start on America's most crucial security and technological innovations.
But there is a problem. The synthetic hallucinogen is beginning to have strange effects on some students, and these effects are being noticed. A bright Israeli E.R. doctor and his wife (an addiction counselor) living and working in Burlington, Vermont, have encountered some of these students suffering from bizarre psychotic symptoms. They suspect that there is more than meets the eye in these Chinese cafés and have started investigating. If the Chinese plan is discovered, it will open the CCP up to significant charges of international terrorism against the United States. With current congressional committee hearings focused on banning Tik Tok and other Chinese technologies, the CCP will stop at nothing to prevent this from happening.
About the Author
Contact Link
No comments: